Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Cell Separation Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global cell separation technologies market reached a value of US$ 7.62 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 19.28 Billion by 2027, exhibiting a CAGR of 16.73% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell separation technologies are a set of techniques, which are extensively deployed for identifying and separating one or more cells from the heterogeneous mixture based on their extracellular properties. They are further utilized in the healthcare sector for dealing with various chronic diseases, such as cancer, acquired immune deficiency syndrome (AIDS) and cystic fibrosis. Some of the most employed techniques for cell separation include microfluidic cell sorting, immunogenicity cell isolation and density gradient configuration. These techniques are applied based on the varying size, density, surface protein expression and shape of the cells.
Cell Separation Technologies Market Trends:
The widespread adoption of cell separation technologies in the pharmaceutical industry to enhance drug discovery and develop drugs with improved efficacies is one of the key factors driving the global cell separation technologies market toward growth. Additionally, the introduction of advanced isolation tools for the continuous examination of nucleic acids, chromatin, proteins, and other complex cells is contributing to the market growth.
In line with this, the increasing requirement for personalized medicines and an enhanced focus on cell-based research are positively impacting the market growth. Moreover, the increasing investments and fundings in the research and development (R&D) activities in the field of biotechnology for developing and utilizing isolated cells for developing novel cell-based treatments and therapies for several chronic ailments is propelling the market growth.
Furthermore, the escalating prevalence of various chronic diseases amongst the geriatric population is positively influencing the market. Other factors, such as the rapid expansion in the pharmaceutical and biotechnology industry and the numerous initiatives undertaken by the governments of several nations for fortifying the healthcare infrastructure by enhancing cell-based technology, are creating a positive outlook for the market.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global cell separation technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cell separation technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the cell type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cell separation technologies market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cell Separation Technologies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Cell Type
7.1 Human Cells
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Animal Cells
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Technology
8.1 Centrifugation-based Cell Separation
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Surface marker-based Cell Separation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Filtration-based Cell Separation
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Oncology Research
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Neuroscience Research
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Stem Cell Research
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Microbiology
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Immunology Research
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by End User
10.1 Research Laboratories and Institute
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Biotechnology and Biopharmaceutical Companies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Cell Banks
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
12 SWOT Analysis
13 Value Chain Analysis
14 Porters Five Forces Analysis
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Akadeum Life Sciences
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Alfa Laval AB
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton, Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bio-Rad Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Corning Incorporated
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck KGaA
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Miltenyi Biotec Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 PerkinElmer Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Stemcell Technologies Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Terumo Corporation
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/kezd2z
Attachment
